✦ LIBER ✦

Immunologic profile in patients with Hodgkin's disease in complete remission

✍ Scribed by A. M. Liberati; E. Ballatori; M. Fizzotti; M. Schippa; M. G. Proietti; R. di Marzio; A. Pecci; L. Biscetti; R. Sbarretti; L. Cini; F. Grignani

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 847 KB
Volume: 59
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19870601)59:11<1906::aid-cncr2820591111>3.0.co;2-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bladder polyp and heavy proteinuria in a

Bladder polyp and heavy proteinuria in a patient with hodgkin's disease in remission

✍ Robert L. Chevalier; Fern G. Campbell; Benjamin C. Sturgill; F. Lee Tucker; Hern 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 323 KB 👁 2 views

A 21-year-old man who developed heavy proteinuria 8 years after remission of Hodgkin's disease treated with MOPP chemotherapy and radiation therapy is reported. Evidence of Hodgkin's disease could not be documented, and minimal changes were revealed by renal biopsy. Proteinuria persisted for 20 mont

Intracranial Hodgkin's disease in two pa

Intracranial Hodgkin's disease in two patients with familial Hodgkin's disease

✍ Ashigbi, Michael Y.; Venkatraj, Usha; Agarwal, Veneeta; Bello, Jackie; Wiernik, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 366 KB 👁 2 views

Intracranial Hodgkin's disease is very rare and is often a terminal event. The case of a 33-year-old man who relapsed in the anterior pituitary gland without other evidence of disease 6 months after extended field radiation therapy for Stage IIA Hodgkin's disease is presented. He remains well with n

Factors affecting remission and survival

Factors affecting remission and survival in patients with advanced hodgkin's disease treated with MVPP

✍ Dr. John Wagstaff; William Steward; Mary Jones; David Deakin; Ian Todd; Peter Wi 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 786 KB

One hundred and fourteen patients with clinical or pathological stages IIIB and IV Hodgkin's disease have been treated with MVPP chemotherapy followed by radiotherapy to sites of previously bulky disease. The minimum follow-up is 2 years with a median of 5 years. The overall remission rate was 92 pe

Hydrocele formation in patients with Hod

Hydrocele formation in patients with Hodgkin's disease

✍ Ching-Hon Pui; Judith Wilimas; Elizabeth Thompson; Bruce L. Webber; H. Omar Hust 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

Monocyte activation in patients with Hod

Monocyte activation in patients with Hodgkin's disease

✍ Maria Kávai; Ernö Berßnyi; Attila Zsindely; Gyula Szegedi; Läszlö Fésüs 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 315 KB

Transglutaminase activity in monocytes and serum lysozyme level were tested in 40 patients with Hodgkin's disease and were found to be significantly increased. Transglutaminase activity in monocytes from patients in a clinicaly active stage of the disease was higher than in clinically inactive cases

Hodgkin's disease in a patient with neur

Hodgkin's disease in a patient with neurofibromatosis

✍ Hideyo Natori; Ken Tanaka; Kaori Shiraishi; Seishi Osabe; Hiroto Jojima; Junichi 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 2 views